Biotech Bytes: Conversations with Biotechnology / Pharmaceutical IT Leaders
Steve Swan
41 episodes
1 week ago
AI in Drug Discovery | #aidrugdiscovery #biotechinnovation #medicalinnovation Amid a rapidly changing biotech landscape, AI is transforming how we discover and develop new medicines. Please visit our website to get more information: https://swangroup.net/ In this episode, I sit down with Smbat Rafayelyan, founder and CEO of Bioneex, a platform that connects early-stage biotech innovators with investors and pharma companies using AI-driven insights. He shares his journey from big pharm...
All content for Biotech Bytes: Conversations with Biotechnology / Pharmaceutical IT Leaders is the property of Steve Swan and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
AI in Drug Discovery | #aidrugdiscovery #biotechinnovation #medicalinnovation Amid a rapidly changing biotech landscape, AI is transforming how we discover and develop new medicines. Please visit our website to get more information: https://swangroup.net/ In this episode, I sit down with Smbat Rafayelyan, founder and CEO of Bioneex, a platform that connects early-stage biotech innovators with investors and pharma companies using AI-driven insights. He shares his journey from big pharm...
AI Trends Reviewed 2024 & 2025 Predictions - Expert Insights From Top Biotech CIOs
Biotech Bytes: Conversations with Biotechnology / Pharmaceutical IT Leaders
1 hour 30 minutes
11 months ago
AI Trends Reviewed 2024 & 2025 Predictions - Expert Insights From Top Biotech CIOs
Hi Everyone! Welcome to the Biotech Bytes by The Swan GroupAs we close out 2024 and look toward 2025, what lessons has AI taught us, and what can we expect in the future? Please visit our website to get more information: https://swangroup.net/ In this powerful discussion, eight biotech and technology CIOs—Bill Pierce, Ganesh Iyer, Bill Wallace, Rajvir Madan, Shola Oyewole, Eduard de Vries Sands, Elisabeth Schwartz, and James Schluter—reflect on AI's real-world impact in 2024 and share bo...
Biotech Bytes: Conversations with Biotechnology / Pharmaceutical IT Leaders
AI in Drug Discovery | #aidrugdiscovery #biotechinnovation #medicalinnovation Amid a rapidly changing biotech landscape, AI is transforming how we discover and develop new medicines. Please visit our website to get more information: https://swangroup.net/ In this episode, I sit down with Smbat Rafayelyan, founder and CEO of Bioneex, a platform that connects early-stage biotech innovators with investors and pharma companies using AI-driven insights. He shares his journey from big pharm...
